American International Group, Inc. Vincerx Pharma, Inc. Transaction History

American International Group, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.0 - $0.0 $0 - $0	-8,157 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$0.0 - $0.0 $0 - $0	-575 Reduced 6.58%	8,157 $33,000
Q4 2021 Feb 11, 2022	BUY	$0.0 - $0.0 $0 - $0	1,594 Added 22.33%	8,732 $89,000
Q3 2021 Nov 12, 2021	BUY	$0.0 - $0.0 $0 - $0	4,502 Added 170.79%	7,138 $115,000
Q2 2021 Aug 13, 2021	BUY	$0.0 - $27.0 $0 - $71,172	2,636 New	2,636 $34,000

10.7M

Ticker VINC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 21,189,800
Market Cap $14.4M
Description
Vincerx Pharma, Inc., a clinical-stage biopharmaceutical company, researches and develops therapies to address unmet medical needs for the treatment of cancer in the United States. Its lead product candidate is VIP152, a cyclin-dependent kinase-9 inhibitor for treating patients with advanced cancer. The company's preclinical stage product candid...

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

Stay updated on American International Group, Inc. with notifications on news.